By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – TriLink BioTechnologies today announced a distribution deal covering Australia with Astral Scientific for its nucleic acid products.

Products covered by the deal include more than 150 modified nucleotides, custom oligonucleotides, and CleanAmp Hot Start PCR products, San Diego-based TriLink said.

Financial terms of the deal were not disclosed.

Astral supplies core consumables to the clinical diagnostic, life science, and industrial markets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: Icelandic genome sequences, approach to increase CRISPR efficiency, and more.

Testing showing "genetic incompatibilities" have led thousands of couples in Saudi Arabia to call off their weddings, the BBC reports.

Decode Genetics' ability to tell Icelanders, even ones the company hasn't sequenced, about their disease risk brings up ethical questions.

Genetic analysis of Britain's King Richard III and modern descendants of his relatives indicate breaks in the male line.